This week's e-newsletter includes:
An update from Ultragenyx Pharmaceuticals
Announcing FAST's new VP of Genetic Services & Education
A reminder to fill out the diagnostic module in the Global Angelman Syndrome Registry
Support for newly diagnosed families
An update on joint advocacy work with the Angelman Syndrome Foundation (ASF)